These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32950470)

  • 1. Glucose-6-phosphate dehydrogenase deficiency and SARS-CoV-2 mortality: Is there a link and what should we do?
    Nabavi SF; Habtemariam S; Sureda A; Banach M; Berindan-Neagoe I; Cismaru CA; Bagheri M; Bagheri MS; Nabavi SM
    Clin Biochem; 2020 Dec; 86():31-33. PubMed ID: 32950470
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucose-6-Phosphate Dehydrogenase Deficiency and COVID-19 Infection.
    Vick DJ
    Mayo Clin Proc; 2020 Aug; 95(8):1803-1804. PubMed ID: 32680625
    [No Abstract]   [Full Text] [Related]  

  • 3. Methemoglobinemia in Patient with G6PD Deficiency and SARS-CoV-2 Infection.
    Palmer K; Dick J; French W; Floro L; Ford M
    Emerg Infect Dis; 2020 Sep; 26(9):2279-81. PubMed ID: 32579876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of glucose-6-phosphate dehydrogenase (G6PD) status in US military and VA patients with COVID-19 infection.
    Vick DJ
    BMJ Mil Health; 2021 Apr; 167(2):144. PubMed ID: 33243769
    [No Abstract]   [Full Text] [Related]  

  • 5. Glucose-6-phosphate dehydrogenase deficiency enhances Covid-19 infection in elderly people.
    Abdel Hafez SMN
    Bratisl Lek Listy; 2020; 121(11):786-788. PubMed ID: 33164538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose-6-Phosphate Dehydrogenase Deficiency: An Actionable Risk Factor for Patients with COVID-19?
    Jamerson BD; Haryadi TH; Bohannon A
    Arch Med Res; 2020 Oct; 51(7):743-744. PubMed ID: 32600868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abrupt Deterioration of COVID-19 Patients and Spreading of SARS COV-2 Virions in the Lungs.
    Filipovic N; Saveljic I; Hamada K; Tsuda A
    Ann Biomed Eng; 2020 Dec; 48(12):2705-2706. PubMed ID: 33140243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Faecal immunochemical tests in the COVID-19 pandemic; safety-netting of patients with symptoms and low faecal haemoglobin concentration - can a repeat test be used?
    Benton SC; Fraser CG
    Ann Clin Biochem; 2021 May; 58(3):163-165. PubMed ID: 33016079
    [No Abstract]   [Full Text] [Related]  

  • 9. Glucose-6-phosphate dehydrogenase deficiency and COVID-19 mortality.
    Romero JP; Benito-León J
    Minerva Med; 2023 Jun; 114(3):395-396. PubMed ID: 33464223
    [No Abstract]   [Full Text] [Related]  

  • 10. Extrapulmonary SARS-CoV-2 manifestations.
    Carvalho T
    Nat Med; 2020 Dec; 26(12):1806. PubMed ID: 33288941
    [No Abstract]   [Full Text] [Related]  

  • 11. Striking Similarities of Multisystem Inflammatory Syndrome in Children and a Myocarditis-Like Syndrome in Adults: Overlapping Manifestations of COVID-19.
    Most ZM; Hendren N; Drazner MH; Perl TM
    Circulation; 2021 Jan; 143(1):4-6. PubMed ID: 32787714
    [No Abstract]   [Full Text] [Related]  

  • 12. TMPRSS2 activity may mediate sex differences in COVID-19 severity.
    Okwan-Duodu D; Lim EC; You S; Engman DM
    Signal Transduct Target Ther; 2021 Mar; 6(1):100. PubMed ID: 33649313
    [No Abstract]   [Full Text] [Related]  

  • 13. A Case of COVID-19 in a Patient with Asymptomatic Hemoglobin D Thalassemia and Glucose-6-Phosphate Dehydrogenase Deficiency.
    Sasi S; Yassin MA; Nair AP; Al Maslamani MS
    Am J Case Rep; 2020 Jul; 21():e925788. PubMed ID: 32697769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of biomaterials and three dimensional (3D) in vitro tissue models in fighting against COVID-19.
    Seyfoori A; Amereh M; Dabiri SMH; Askari E; Walsh T; Akbari M
    Biomater Sci; 2021 Feb; 9(4):1217-1226. PubMed ID: 33355542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sympathetic activation: a potential link between comorbidities and COVID-19.
    Porzionato A; Emmi A; Barbon S; Boscolo-Berto R; Stecco C; Stocco E; Macchi V; De Caro R
    FEBS J; 2020 Sep; 287(17):3681-3688. PubMed ID: 32779891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Serine Protease 2) Expression and Localization of SARS-CoV-2 Infection in the Human Heart.
    Sakamoto A; Kawakami R; Kawai K; Gianatti A; Pellegrini D; Kutys R; Guo L; Mori M; Cornelissen A; Sato Y; Bellasi A; Faggi L; Hong C; Romero M; Guagliumi G; Virmani R; Finn AV
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):542-544. PubMed ID: 33086866
    [No Abstract]   [Full Text] [Related]  

  • 17. Doubtful precipitation of hemolysis by hydroxychloroquine in glucose-6-phosphate dehydrogenase-deficient patient with COVID-19 infection.
    Afra TP; Vasudevan Nampoothiri R; Razmi T M
    Eur J Haematol; 2020 Oct; 105(4):512-513. PubMed ID: 32500556
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19 spread: The Italian case.
    Harari S; Vitacca M
    Respir Med Res; 2020 Nov; 78():100771. PubMed ID: 32502937
    [No Abstract]   [Full Text] [Related]  

  • 19. Is glucose-6-phosphatase dehydrogenase deficiency associated with severe outcomes in hospitalized COVID-19 patients?
    Kumar N; AbdulRahman A; AlAwadhi AI; AlQahtani M
    Sci Rep; 2021 Sep; 11(1):19213. PubMed ID: 34584152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 infection unmasking glucose-6-phosphate dehydrogenase deficiency.
    Devarashetty SP; Ponna PK; Devarakonda V; Ramadas P
    QJM; 2022 Nov; 115(11):771-772. PubMed ID: 35904760
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.